NDC 0071-2418

Zarontin

Ethosuximide

Zarontin is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Parke-davis Div Of Pfizer Inc. The primary component is Ethosuximide.

Product ID0071-2418_098479ec-293c-4bc5-80d2-0202dc239d3b
NDC0071-2418
Product TypeHuman Prescription Drug
Proprietary NameZarontin
Generic NameEthosuximide
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date2002-02-27
Marketing CategoryANDA / ANDA
Application NumberANDA080258
Labeler NameParke-Davis Div of Pfizer Inc
Substance NameETHOSUXIMIDE
Active Ingredient Strength250 mg/5mL
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0071-2418-23

1 BOTTLE, GLASS in 1 CARTON (0071-2418-23) > 474 mL in 1 BOTTLE, GLASS
Marketing Start Date2002-02-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0071-2418-35 [00071241835]

Zarontin SOLUTION
Marketing CategoryANDA
Application NumberANDA080258
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2020-03-10

NDC 0071-2418-23 [00071241823]

Zarontin SOLUTION
Marketing CategoryANDA
Application NumberANDA080258
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2002-02-27

Drug Details

Active Ingredients

IngredientStrength
ETHOSUXIMIDE250 mg/5mL

OpenFDA Data

SPL SET ID:7bf3e616-45e8-4469-a75d-4d824ce951ea
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 755357
  • 251322

    • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]

    NDC Crossover Matching brand name "Zarontin" or generic name "Ethosuximide"

    NDCBrand NameGeneric Name
    0071-0237ZarontinEthosuximide
    0071-2418ZarontinEthosuximide
    0093-9660EthosuximideEthosuximide
    0121-0670ETHOSUXIMIDEETHOSUXIMIDE
    23155-532ETHOSUXIMIDEETHOSUXIMIDE
    42806-711EthosuximideEthosuximide
    46672-641ethosuximideethosuximide
    59762-2250EthosuximideEthosuximide
    59762-2350EthosuximideEthosuximide
    61748-024EthosuximideEthosuximide
    61748-025EthosuximideEthosuximide
    63629-8005EthosuximideEthosuximide
    64380-878ETHOSUXIMIDEETHOSUXIMIDE
    68382-443ethosuximideethosuximide
    69387-108EthosuximideEthosuximide
    69452-152EthosuximideEthosuximide

    Trademark Results [Zarontin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZARONTIN
    ZARONTIN
    72078062 0704519 Live/Registered
    Parke, Davis & Company
    1959-07-20
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.